First, human lung cancer EGFR-TKI resistant cell lines were generated by increasing concentrations of EGFR-TKI in the culture of PC9 and HCC827 cells in vitro, both harboring EGFRΔ19 mutations. This evidence concerns the gene EGFR and lung cancer.